Skyward Specialty Insurance Group, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Skyward Specialty Insurance Group, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.42B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $1.15B | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $885.97M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $642.42M | Sep 5, 2025 |
| FY2022 | Dec 31, 2021 | $550.18M | Mar 28, 2023 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.38M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $10.68M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $9.82M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $5.20M | Sep 5, 2025 |
| FY2022 | Dec 31, 2021 | $3.97M | Mar 28, 2023 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $170.03M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $118.83M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $85.98M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $39.40M | Sep 5, 2025 |
| FY2022 | Dec 31, 2021 | $38.32M | Mar 28, 2023 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $408.08M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $305.12M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $338.19M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $208.94M | Sep 5, 2025 |
| FY2022 | Dec 31, 2021 | $175.29M | Mar 28, 2023 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.45M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $4.22M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $3.11M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $2.33M | Sep 5, 2025 |
| FY2022 | Dec 31, 2021 | $2.15M | Mar 28, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.79B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $3.73B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $2.95B | Sep 5, 2025 |
| FY2023 | Dec 31, 2022 | $2.36B | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $2.12B | Mar 28, 2023 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.78B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $2.94B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $2.29B | Sep 5, 2025 |
| FY2023 | Dec 31, 2022 | $1.94B | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $1.69B | Mar 28, 2023 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.01B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $794.00M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $661.03M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $421.66M | Sep 5, 2025 |
| FY2022 | Dec 31, 2021 | $426.08M | Mar 28, 2023 |
| FY2022 | Dec 31, 2020 | $303.22M | Mar 28, 2023 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $65.73M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $65.73M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $65.73M | Sep 5, 2025 |
| FY2023 | Dec 31, 2022 | $65.73M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $65.73M | Mar 28, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $267.15M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $97.12M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | ($21.71M) | Sep 5, 2025 |
| FY2023 | Dec 31, 2022 | ($105.42M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($144.81M) | Mar 28, 2023 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $168.54M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $121.60M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $65.89M | Sep 5, 2025 |
| FY2023 | Dec 31, 2022 | $45.44M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $42.11M | Mar 28, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Sep 5, 2025 |
| FY2022 | Dec 31, 2021 | 1 | Mar 28, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Sep 5, 2025 |
| FY2022 | Dec 31, 2021 | 1 | Mar 28, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 40.51M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 40.13M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | 39.86M | Sep 5, 2025 |